SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 58 filers reported holding SYNERON MEDICAL LTD in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,093,000 | +116.0% | 198,453 | +71.9% | 0.15% | +117.9% |
| Q4 2016 | $969,000 | +147.2% | 115,428 | +110.7% | 0.07% | +139.3% |
| Q3 2016 | $392,000 | +11.0% | 54,789 | +19.1% | 0.03% | +16.7% |
| Q2 2016 | $353,000 | -9.5% | 45,992 | -13.9% | 0.02% | -7.7% |
| Q1 2016 | $390,000 | -53.2% | 53,395 | -50.6% | 0.03% | -56.7% |
| Q4 2015 | $833,000 | +64.6% | 108,108 | +52.5% | 0.06% | +66.7% |
| Q3 2015 | $506,000 | -55.8% | 70,877 | -34.4% | 0.04% | -57.6% |
| Q2 2015 | $1,146,000 | -31.1% | 107,966 | -19.7% | 0.08% | -26.1% |
| Q1 2015 | $1,663,000 | +122.3% | 134,385 | +123.4% | 0.12% | +125.5% |
| Q1 2014 | $748,000 | -16.0% | 60,141 | -17.1% | 0.05% | -32.0% |
| Q4 2013 | $891,000 | +510.3% | 72,504 | +328.0% | 0.08% | +400.0% |
| Q3 2013 | $146,000 | -85.8% | 16,940 | -85.7% | 0.02% | -88.1% |
| Q2 2013 | $1,030,000 | – | 118,449 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $31,650,000 | 4.86% |
| Discovery Group I, LLC | 1,221,310 | $12,885,000 | 4.30% |
| Kenmare Capital Partners, L.L.C. | 389,177 | $4,106,000 | 3.98% |
| Profit Investment Management, LLC | 237,217 | $2,503,000 | 2.03% |
| Senvest Management, LLC | 2,202,272 | $23,234,000 | 1.66% |
| PERRITT CAPITAL MANAGEMENT INC | 426,370 | $4,498,000 | 1.14% |
| Camber Capital Management LP | 2,347,593 | $24,767,000 | 1.00% |
| DALTON GREINER HARTMAN MAHER & CO | 1,645,048 | $17,355,000 | 0.99% |
| Lapides Asset Management, LLC | 396,800 | $4,186,000 | 0.78% |
| DAFNA Capital Management LLC | 85,947 | $907,000 | 0.77% |